July 31, 2019

CB2 Insights, a leading data-driven company focused on bringing real-world evidence driven from the point-of-care to the medical cannabis community, has appointed former Johnson & Johnson executive Peter Cummins as a Director to its Board, increasing the size of its Board of Directors to seven members.

“The high interest and development potential that exists between medical cannabis and traditional...

July 18, 2019

CB2 Insights, a leading data-driven company focused on bringing Real-World Evidence driven from the point-of-care to the medical cannabis community, announced that it has been selected as exclusive research technology platform for the leading, and only, independent scientific body on drugs in the UK, working to provide evidence-based information on safety and efficacy within medical cannabis. A Le...

July 16, 2019

Vireo Health, one of the first medical marijuana companies to be licensed in New York, announced the launch of the state’s first same-day marijuana delivery service. Patients living in the New York City metro area, Westchester County and Nassau County will now have access to free, same-day home delivery. This is the first time that medical marijuana will be available to patients in New York via sa...

July 4, 2019

Bruce Linton, former CEO/Chairman of Canopy Growth. Photo credit: Bloomberg

In the wake of Canopy CEO/Chairman Bruce Linton's departure earlier this week, Barron's followed up with Merida Managing Partner Mitch Baruchowitz, who predicted last year that Constellation would soon assert its over Canopy. 

“When you write a $4 billion check, you have certain expectations,” Baruch...

Please reload

Featured Posts

Investing in Cannabis: Mitch Baruchowitz

May 21, 2019

1/10
Please reload

Archive
Please reload

Have a question? Want to learn more?

641 Lexington Avenue, Suite 1801, New York, NY  10022

©2019 Merida Capital Partners. Proudly created by Rapid Fig with Wix.com